Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1308525/full |
| _version_ | 1797487812432363520 |
|---|---|
| author | Carlos Gil Ferreira Marina Xavier Reis Gilson Gabriel Viana Veloso |
| author_facet | Carlos Gil Ferreira Marina Xavier Reis Gilson Gabriel Viana Veloso |
| author_sort | Carlos Gil Ferreira |
| collection | DOAJ |
| first_indexed | 2024-03-09T23:53:08Z |
| format | Article |
| id | doaj.art-f877df3f574d48bfb56ab3e342332fd8 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-09T23:53:08Z |
| publishDate | 2023-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-f877df3f574d48bfb56ab3e342332fd82023-11-23T16:30:29ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-11-011310.3389/fonc.2023.13085251308525Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancerCarlos Gil FerreiraMarina Xavier ReisGilson Gabriel Viana Velosohttps://www.frontiersin.org/articles/10.3389/fonc.2023.1308525/fullNSCLC - lung adenocarcinoma - EGFR - ALK - BRAF - KRAS - RET - MET - PD-L1 - ROS1NGS - next generation sequencingmolecular profilingliquid biopsydriver mutationstarget therapy |
| spellingShingle | Carlos Gil Ferreira Marina Xavier Reis Gilson Gabriel Viana Veloso Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer Frontiers in Oncology NSCLC - lung adenocarcinoma - EGFR - ALK - BRAF - KRAS - RET - MET - PD-L1 - ROS1 NGS - next generation sequencing molecular profiling liquid biopsy driver mutations target therapy |
| title | Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer |
| title_full | Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer |
| title_fullStr | Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer |
| title_full_unstemmed | Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer |
| title_short | Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer |
| title_sort | editorial molecular genetic testing and emerging targeted therapies for non small cell lung cancer |
| topic | NSCLC - lung adenocarcinoma - EGFR - ALK - BRAF - KRAS - RET - MET - PD-L1 - ROS1 NGS - next generation sequencing molecular profiling liquid biopsy driver mutations target therapy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1308525/full |
| work_keys_str_mv | AT carlosgilferreira editorialmoleculargenetictestingandemergingtargetedtherapiesfornonsmallcelllungcancer AT marinaxavierreis editorialmoleculargenetictestingandemergingtargetedtherapiesfornonsmallcelllungcancer AT gilsongabrielvianaveloso editorialmoleculargenetictestingandemergingtargetedtherapiesfornonsmallcelllungcancer |